Search
for
Sort by
Research 31–60 of 1000+
- Alopecia
- Regulatory T cells in skin
- MicroRNA-214 controls skin and hair follicle development by modulating the activity of the Wnt pathway
- TGFβ and cancer metastasis: an inflammation link
- Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
- Proteolysis‐targeting chimeras in cancer therapy: Targeted protein degradation for next‐generation treatment
- What’s Diet Got to Do With It? Basic and Clinical Science Behind Diet and Acne
- Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Premature aging and cancer development in transgenic mice lacking functional CYLD
- Ottawa, Ontario, Canada, February 13–16, 2013
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- Qualitative and Quantitative Assessment of Taste and Smell Changes in Patients Undergoing Chemotherapy for Breast Cancer or Gynecologic Malignancies
- EMT Factors and Metabolic Pathways in Cancer
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- Selective Androgen Receptor Modulators (SARMs) Negatively Regulate Triple-Negative Breast Cancer Growth and Epithelial:Mesenchymal Stem Cell Signaling
- Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases
- 532P Analyses of patient-reported outcomes (PROs) with mirvetuximab soravtansine (MIRV) versus standard chemotherapy in the randomized phase III FORWARD I study in ovarian cancer (GOG 3011)
- Evaluation of the CNC® prosthetic system in recurrent breast cancer patients with chemotherapy-induced alopecia: a pilot study
- Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
- BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer
- Ayurveda & Bioactives as Adjuvant for Dna Modulation in Cancer Treatment & Adverse Drug Reaction [ADR] – A Glimpse of Traditional Indian Nanotechnology
- Patient, Oncologist, and Payer Preferences for Adjuvant Endocrine Therapy and CDK4/6 Inhibitor Regimens in Early-Stage Breast Cancer: A Discrete Choice Experiment
- The color of skin: white diseases of the skin, nails, and mucosa
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- The polycystic ovary syndrome
- Significance of stress keratin expression in normal and diseased epithelia
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Reduced SMAD2/3 activation independently predicts increased depth of human cutaneous squamous cell carcinoma